<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0">
  <channel>
    <title>Colorectal Cancer News Articles Provided by Cancer Compass</title>
    <description>CancerCompass is dedicated to provided you with the most up to date cancer information and news. Visit our website to find all our articles on Colorectal Cancer News</description>
    <link>http://www.cancercompass.com/colorectal-cancer-news.htm</link>
    <pubDate>Sat, 07 Nov 2009 00:00:00 GMT</pubDate>
    <lastBuildDate>Sat, 07 Nov 2009 00:00:00 GMT</lastBuildDate>
    <docs>http://backend.userland.com/rss</docs>
    <generator>RSS.NET: http://www.rssdotnet.com/</generator>
    <item>
      <title>Antipsychotic Drugs Fight Cancer</title>
      <description>Drugs used to treat psychiatric disorders are  highly effective at killing cancer cells,  opening up potential new lines of treatments. Dr  Louise Lurze-Mann of the University of NSW  School of Biotechnology and Biomolecular  Sciences was talking with psychiatric  researchers at the University of Queensland when  they mentioned that people with diseases like  schizophrenia appear to have low rates of  cancer, despite being more inclined to smoke  than the general population.</description>
      <link>http://www.cancercompass.com/cancer-news/article/32367.htm</link>
      <author>CancerCompass</author>
      <pubDate>Fri, 06 Nov 2009 00:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Clinical Trial Promotes New Standards For Colorectal Cancer Treatment</title>
      <description>In a review article published this month in The  Oncologist, UNC's Dr. Richard M. Goldberg and a  team of colleagues catalogue how the data  collected in a single large comparative clinical  trial testing combination chemotherapy for  metastatic colorectal cancer has been used not  only to benefit the patients that enrolled but  also patients who subsequently developed the  disease.</description>
      <link>http://www.cancercompass.com/cancer-news/article/32358.htm</link>
      <author>CancerCompass</author>
      <pubDate>Fri, 06 Nov 2009 00:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Sweet Potatoes Make For A Hearty Soup Base</title>
      <description>It's a safe bet to presume there are soup recipes in today's column because it's colder, furnaces are running and it just seems like a fall thing to do. </description>
      <link>http://www.cancercompass.com/cancer-news/article/32365.htm</link>
      <author>CancerCompass</author>
      <pubDate>Fri, 06 Nov 2009 00:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Newly Found Molecule Disrupts Cancer Cells</title>
      <description>U.S. scientists say they have discovered a small  molecule that inhibits the actions of a protein  cancer cells require for survival. The  researchers said they determined the molecule,  called PES, inhibits a type of protein called a  heat-shock protein that helps cells survive  heat, lack of nutrients and other cell-damaging  conditions.</description>
      <link>http://www.cancercompass.com/cancer-news/article/32368.htm</link>
      <author>CancerCompass</author>
      <pubDate>Fri, 06 Nov 2009 00:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Alternatively Spliced Tissue Factor Identified As Promising New Biomarker For Aggressive Cancers</title>
      <description>A recently discovered form of the protein that  triggers blood clotting may play a key role in  the molecular mechanisms leading to the growth  of certain metastatic cancers, according to new  research reported by an international team of  scientists.</description>
      <link>http://www.cancercompass.com/cancer-news/article/32371.htm</link>
      <author>CancerCompass</author>
      <pubDate>Fri, 06 Nov 2009 00:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Obesity Linked To Specific Cancers</title>
      <description>About 100,500 new cases of cancer are caused by  obesity every year, according to the most  comprehensive attempt ever to estimate the  cancers attributed to extra weight. The  analysis, released today by the American  Institute for Cancer Research, is based on  updated cancer data and a report released  earlier this year by a panel of experts. Among  the types of cancer most strongly linked to  excess body fat:</description>
      <link>http://www.cancercompass.com/cancer-news/article/32377.htm</link>
      <author>CancerCompass</author>
      <pubDate>Fri, 06 Nov 2009 00:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Stuffed Acorn Squash Makes A Hearty Entree</title>
      <description>Mollie Katzen's latest cookbook urges beginners  to take on her challenge with easy recipes, such  as this acorn squash entree. Use plain raw  almonds, not roasted or salted, Katzen writes,  and don't chop them too fine.  You can cook the rice and bake the acorn squash  at the same time.</description>
      <link>http://www.cancercompass.com/cancer-news/article/32356.htm</link>
      <author>CancerCompass</author>
      <pubDate>Wed, 04 Nov 2009 00:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Light Stews Still Hearty: Reduce Fat And Salt In Fall Soups</title>
      <description>If you're watching your weight, soup can be  deceptive. What could be more harmless for lunch  or a light dinner? Not so fast. Depending on the  recipe, some soups are full of cream and cheese,  or sometimes worse, they start with a roux. In  place of cream and butter, add flavor to soup  with lots of vegetables, beef broth and dried  and fresh herbs.</description>
      <link>http://www.cancercompass.com/cancer-news/article/32357.htm</link>
      <author>CancerCompass</author>
      <pubDate>Wed, 04 Nov 2009 00:00:00 GMT</pubDate>
    </item>
    <item>
      <title>NCCN Updates Colorectal Screening Guidelines To Include Additional Primary Screening Modality</title>
      <description>Although colonoscopy remains the preferred  colorectal cancer screening method, the recently  updated NCCN Guidelines for Colorectal Cancer  Screening have added annual immunohistochemical  stool testing with or without a flexible  sigmoidoscopy every five years as an alternate  screening option for average risk individuals.  Additional updates include guidelines for  individuals with three rare syndromes putting  them at greater risk for developing the disease.</description>
      <link>http://www.cancercompass.com/cancer-news/article/32340.htm</link>
      <author>CancerCompass</author>
      <pubDate>Tue, 03 Nov 2009 00:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Coffee Brims With Health Benefits, Researchers Say</title>
      <description>Drink up, coffee lovers. Not only is coffee  aromatic and delicious, it's good for you. Who  says? None other than Harvard Medical School.  Once considered questionable for your health, it  turns out that the beloved beverage is actually  healthful in moderation. That means a few cups a  day.</description>
      <link>http://www.cancercompass.com/cancer-news/article/32341.htm</link>
      <author>CancerCompass</author>
      <pubDate>Tue, 03 Nov 2009 00:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Gastrocor Introduces New FISH Test For Colorectal Cancer Detection</title>
      <description>GastroFISH(TM) is the first tissue-based  fluorescence in situ hybridization (FISH) test  for the detection of chromosomal anomalies  associated with colon cancer.</description>
      <link>http://www.cancercompass.com/cancer-news/article/32324.htm</link>
      <author>CancerCompass</author>
      <pubDate>Fri, 30 Oct 2009 00:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Clinical Trial Promotes New Standards For Colorectal Cancer Treatment</title>
      <description>In a review article published this month in The  Oncologist, UNC's Dr. Richard M. Goldberg and a  team of colleagues catalogue how the data  collected in a single large comparative clinical  trial testing combination chemotherapy for  metastatic colorectal cancer has been used not  only to benefit the patients that enrolled but  also patients who subsequently developed the  disease.</description>
      <link>http://www.cancercompass.com/cancer-news/article/32312.htm</link>
      <author>CancerCompass</author>
      <pubDate>Wed, 28 Oct 2009 00:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Does It Make Sense To Offer Cancer Screenings To Older Adults? Experts' Opinions Vary</title>
      <description>Does it make sense to offer cancer screenings  to  older adults? Experts' opinions vary. The   Tribune asked several leading organizations to   describe their policies for people considered  to  be low risk, without symptoms of potential   illness.</description>
      <link>http://www.cancercompass.com/cancer-news/article/32319.htm</link>
      <author>CancerCompass</author>
      <pubDate>Wed, 28 Oct 2009 00:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Research from University of Colorado, Medical Department has provided new information about colon cancer</title>
      <description>According to recent research from the United  States, Despite effective prevention and early  detection screening methods, colorectal cancer  is the second leading cause of cancer death in  the United States. Colorectal cancer screening  community-based interventions are rare, and the  literature lacks information about community- based intervention processes.</description>
      <link>http://www.cancercompass.com/cancer-news/article/32284.htm</link>
      <author>CancerCompass</author>
      <pubDate>Fri, 23 Oct 2009 00:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Spectrum Pharmaceuticals Receives Complete Response Letter from FDA for FUSILEV in Advanced Metastatic Colorectal Cancer</title>
      <description>Spectrum Pharmaceuticals, a commercial-stage  biotechnology company with a primary focus in  oncology, announced that it received a Complete  Response letter from the U.S. Food and Drug  Administration (FDA) regarding its supplemental  New Drug Application (sNDA) for FUSILEV  (levoleucovorin) for injection for treatment of  patients with advanced metastatic colorectal  cancer.</description>
      <link>http://www.cancercompass.com/cancer-news/article/32285.htm</link>
      <author>CancerCompass</author>
      <pubDate>Fri, 23 Oct 2009 00:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Researchers At World Health Organization Have Published New Data On Colon Cancer</title>
      <description>Increased levels of vitamin D and calcium may   play a protective role in colorectal cancer   (CRC) risk. It has been suggested that these   effects may be mediated by genetic variants of   the vitamin D receptor (VDR) and the calcium   sensing receptor (CASR), scientists in Lyon,   France report.</description>
      <link>http://www.cancercompass.com/cancer-news/article/32305.htm</link>
      <author>CancerCompass</author>
      <pubDate>Sun, 25 Oct 2009 00:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Chronic Pain Treatments Work Better Together, Says Anesthesiologist</title>
      <description>People who suffer from debilitating neuropathic  pain may get more relief and sleep better by  combining two commonly-prescribed drugs. A new,  federally-funded study by Queen's University  researchers has found that taking the drugs  together is a more effective treatment than  taking either of them individually.</description>
      <link>http://www.cancercompass.com/cancer-news/article/32310.htm</link>
      <author>CancerCompass</author>
      <pubDate>Wed, 28 Oct 2009 00:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Unusual Metals Might Lead To Better Drugs</title>
      <description>British medical scientists say they've  demonstrated that unusual metal compounds can be  used to form effective cancer drugs. Researchers  at the University of Leeds and the University of  Warwick said such metals can form an effective  treatment against colon and ovarian cancer,  including cancerous cells that have developed  immunity to other drugs.</description>
      <link>http://www.cancercompass.com/cancer-news/article/16478.htm</link>
      <author>CancerCompass</author>
      <pubDate>Wed, 21 Oct 2009 00:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Investigators At Massachusetts General Hospital Have Published New Data On Colon Cancer</title>
      <description>Although evidence suggests that aspirin and  celecoxib may reduce the risk of colorectal  cancer (CRC), these drugs can also cause harmful  side effects. The aim of this study was to  characterize patient preferences for celecoxib  and aspirin, scientists in the United States  report.</description>
      <link>http://www.cancercompass.com/cancer-news/article/16451.htm</link>
      <author>CancerCompass</author>
      <pubDate>Sat, 17 Oct 2009 00:00:00 GMT</pubDate>
    </item>
    <item>
      <title>More Efficient Colonoscopies Suggested</title>
      <description>U.S. medical scientists say they have determined  how physicians can lowers their costs and reduce  waiting times for patients undergoing  colonoscopies. Colorectal cancer is a leading  cause of cancer-related deaths in the United  States, but the disease can be managed with  early screening using a procedure called a  colonoscopy.</description>
      <link>http://www.cancercompass.com/cancer-news/article/16407.htm</link>
      <author>CancerCompass</author>
      <pubDate>Thu, 08 Oct 2009 00:00:00 GMT</pubDate>
    </item>
  </channel>
</rss>